Skip to main navigation Skip to search Skip to main content

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

  • Marcin F Osuchowski
  • , Martin S Winkler
  • , Tomasz Skirecki
  • , Sara Cajander
  • , Manu Shankar-Hari
  • , Gunnar Lachmann
  • , Guillaume Monneret
  • , Fabienne Venet
  • , Michael Bauer
  • , Frank M Brunkhorst
  • , Sebastian Weis
  • , Alberto Garcia-Salido
  • , Matthijs Kox
  • , Jean-Marc Cavaillon
  • , Florian Uhle
  • , Markus A Weigand
  • , Stefanie B Flohé
  • , W Joost Wiersinga
  • , Raquel Almansa
  • , Amanda de la Fuente
  • Ignacio Martin-Loeches, Christian Meisel, Thibaud Spinetti, Joerg C Schefold, Catia Cilloniz, Antoni Torres, Evangelos J Giamarellos-Bourboulis, Ricard Ferrer, Massimo Girardis, Andrea Cossarizza, Mihai G Netea, Tom van der Poll, Jesús F Bermejo-Martín, Ignacio Rubio

Research output: Contribution to journal › Article › peer-review

Abstract

The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with devastating consequences. While the medical community has gained insight into the epidemiology of COVID-19, important questions remain about the clinical complexities and underlying mechanisms of disease phenotypes. Severe COVID-19 most commonly involves respiratory manifestations, although other systems are also affected, and acute disease is often followed by protracted complications. Such complex manifestations suggest that SARS-CoV-2 dysregulates the host response, triggering wide-ranging immuno-inflammatory, thrombotic, and parenchymal derangements. We review the intricacies of COVID-19 pathophysiology, its various phenotypes, and the anti-SARS-CoV-2 host response at the humoral and cellular levels. Some similarities exist between COVID-19 and respiratory failure of other origins, but evidence for many distinctive mechanistic features indicates that COVID-19 constitutes a new disease entity, with emerging data suggesting involvement of an endotheliopathy-centred pathophysiology. Further research, combining basic and clinical studies, is needed to advance understanding of pathophysiological mechanisms and to characterise immuno-inflammatory derangements across the range of phenotypes to enable optimum care for patients with COVID-19.
Original languageEnglish
Pages (from-to)622-642
Number of pages21
JournalThe Lancet Respiratory Medicine
Volume9
Issue number6
DOIs
Publication statusPublished - 6 May 2021

Fingerprint

Dive into the research topics of 'The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity'. Together they form a unique fingerprint.

Cite this